References
- Gramatges MM, Bertuch AA. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res. 2013;162(6):353–363.
- Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med. 2010;12(12):753–764.
- Bhala S, Best AF, Giri N, et al. CNS manifestations in patients with telomere biology disorders. Neurol Genet. 2019;5(6):370. https://ng.neurology.org/content/5/6/370
- García MSF, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med. 2014;5:157–167.
- Alter BP, Giri N, Savage SA, et al. Cancer in dyskeratosis congenita. Blood. 2009;113(26):6549–6557.
- Schratz KE, Haley L, Danoff SK, et al. Cancer spectrum and outcomes in the Mendelian short telomere syndromes. Blood. 2020;135(22):1946–1956.
- Borie R, Kannengiesser C, Fontbrune F, et al. Management of suspected monogenic lung fibrosis in a specialised Centre. Eur Respir Rev. 2017;26(144):160122.
- Hoareau-Aveilla C, Bonoli M, Caizergues-Ferrer M, et al. hNaf1 is required for accumulation of human box H/ACA snoRNPs, scaRNPs, and telomerase. RNA. 2006;12(5):832–840.
- Stanley SE, Gable DL, Wagner CL, et al. Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema. Sci Transl Med. 2016;8(351):351ra107.
- Stańczak P, Witecka J, Szydło A, et al. Mutations in mammalian tolloid-like 1 gene detected in adult patients with ASD. Eur J Hum Genet. 2009;17(3):344–351.
- Fuller ZL, Berg JJ, Mostafavi H, et al. Measuring intolerance to mutation in human genetics. Nat Genet. 2019; May51(5):772–776.
- Glousker G, Touzot F, Revy P, et al. Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder. Br J Haematol. 2015;170(4):457–471.
- Ip P, Knight R, Dokal I, et al. Peripheral neuropathy–a novel finding in dyskeratosis congenita. Eur J Paediatr Neurol. 2005;9(2):85–89.
- Lobanova A, She R, Pieraut S, et al. Different requirements of functional telomeres in neural stem cells and terminally differentiated neurons. Genes Dev. 2017;31(7):639–647.
- Greenberg SA. Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol. 2019;15(5):257–272.
- Morosetti R, Broccolini A, Sancricca C, et al. Increased aging in primary muscle cultures of sporadic inclusion-body myositis. Neurobiol Aging. 2010;31(7):1205–1214.